文献速递心脑血管急症重症综合管理与镇静镇痛

整合STOP-BANG评分与临床数据预测心肌梗死后心血管事件:一项机器学习研究

Integrating the STOP-BANG Score and Clinical Data to Predict Cardiovascular Events After Infarction: A Machine Learning Study.
PubMed 文献 · Chest · 2020-04-25
一句话结论在急性心肌梗死患者中,机器学习整合STOP-BANG评分、Killip分级、GRACE评分及简单实验室指标,可优化院内不良心血管事件的识别。

该前瞻性观察性队列研究纳入124例急性心肌梗死患者,按STOP-BANG评分分为低危34例(27.4%)、中危30例(24.2%)、高危60例(48.4%)。机器学习从47个变量中筛选出7个可获取变量(Killip分级、白细胞、GRACE评分、C反应蛋白、血氧饱和度、STOP-BANG评分、N末端B型利钠肽原),整合后预测院内不良心血管事件(死亡、室性心律失常、房颤、再发心绞痛、再梗死、卒中、心衰恶化或心源性休克)的AUC为0.83(95%CI 0.74-0.90),优于所有单一指标(P<.01)。低、中、高危OSA风险组的心血管事件比例递增(P=.005)。

要点

  • 机器学习筛选出7个床旁可获取变量(Killip分级、白细胞、GRACE评分、C反应蛋白、血氧饱和度、STOP-BANG评分、NT-proBNP),整合后预测院内不良心血管事件AUC为0.83(95%CI 0.74-0.90),优于单一指标(P<.01)。
  • STOP-BANG评分低危34例(27.4%)、中危30例(24.2%)、高危60例(48.4%),三组间院内不良心血管事件比例递增(P=.005)。
  • 该模型预测的院内事件包括死亡、室性心律失常、房颤、再发心绞痛、再梗死、卒中、心衰恶化和心源性休克。

适用人群与场景

  • 急性心肌梗死患者,共124例,均为院内随访至出院。

诊断标准与关键阈值

  • STOP-BANG评分将患者分为低危(34例,27.4%)、中危(30例,24.2%)、高危(60例,48.4%)。

研究设计与关键结果

  • 前瞻性观察性队列研究,纳入124例急性心肌梗死患者,院内随访。
  • 机器学习从47个变量(含STOP-BANG评分、Killip分级、GRACE评分、左心室射血分数)中筛选出7个可获取变量:Killip分级、白细胞、GRACE评分、C反应蛋白、血氧饱和度、STOP-BANG评分、N末端B型利钠肽原。
  • 7变量整合模型预测院内不良心血管事件的AUC为0.83(95%CI 0.74-0.90),优于STOP-BANG评分、Killip分级、GRACE评分和左心室射血分数的独立预测(P<.01)。
  • 低、中、高危OSA风险组院内不良心血管事件比例递增(P=.005)。
  • 院内不良心血管事件定义:死亡、室性心律失常、房颤、再发心绞痛、再梗死、卒中、心衰恶化或心源性休克。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,将STOP-BANG评分纳入急性心肌梗死患者的临床评估(考虑Killip分级、GRACE评分和简单实验室值)可通过机器学习显著优化对院内不良心血管事件患者的识别。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: OSA conveys worse clinical outcomes in patients with coronary artery disease. The STOP-BANG score is a simple tool that evaluates the risk of OSA and can be added to the large number of clinical variables and scores that are obtained during the management of patients with myocardial infarction (MI). Currently, machine learning (ML) is able to select and integrate numerous variables to optimize prediction tasks.

RESEARCH QUESTION: Can the integration of STOP-BANG score with clinical data and scores through ML better identify patients who experienced an in-hospital cardiovascular event after acute MI?

STUDY DESIGN AND METHODS: This is a prospective observational cohort study of 124 patients with acute MI of whom the STOP-BANG score classified 34 as low (27.4%), 30 as intermediate (24.2%), and 60 as high (48.4%) OSA-risk patients who were followed during hospitalization. ML implemented feature selection and integration across 47 variables (including STOP-BANG score, Killip class, GRACE score, and left ventricular ejection fraction) to identify those patients who experienced an in-hospital cardiovascular event (ie, death, ventricular arrhythmias, atrial fibrillation, recurrent angina, reinfarction, stroke, worsening heart failure, or cardiogenic shock) after definitive MI treatment. Receiver operating characteristic curves were used to compare ML performance against STOP-BANG score, Killip class, GRACE score, and left ventricular ejection fraction, independently.

RESULTS: There were an increasing proportion of cardiovascular events across the low, intermediate, and high OSA risk groups (P = .005). ML selected 7 accessible variables (ie, Killip class, leukocytes, GRACE score, c reactive protein, oxygen saturation, STOP-BANG score, and N-terminal prohormone of B-type natriuretic peptide); their integration outperformed all comparators (area under the curve, 0.83 [95% CI, 0.74-0.90]; P < .01).

INTERPRETATION: The integration of the STOP-BANG score into clinical evaluation (considering Killip class, GRACE score, and simple laboratory values) of subjects who were admitted for an acute MI because of ML can significantly optimize the identification of patients who will experience an in-hospital cardiovascular event.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Calvillo-Argüelles O, Sierra-Fernández CR, Padilla-Ibarra J, et al. Integrating the STOP-BANG Score and Clinical Data to Predict Cardiovascular Events After Infarction: A Machine Learning Study. Chest. 2020. PMID: 32343966. doi:10.1016/j.chest.2020.03.074

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。